We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » NIH to Test Remdesivir With Eli Lilly’s Olumiant for COVID-19
NIH to Test Remdesivir With Eli Lilly’s Olumiant for COVID-19
The National Institutes of Health is sponsoring a clinical trial of Gilead Sciences’ antiviral remdesivir combined with Eli Lilly’s anti-inflammatory Olumiant (baricitinib) for treatment of COVID-19 infections.